How much does stem cell therapy for Knee Osteoarthritis cost? (2026)
The comparison dataset stores a Bulgaria planning observation of €3,000–€8,000 for treatment, compiled from cited public commercial sources. It is not a quotation from Stem Plus, and different products, doses, visits and inclusions must not be treated as equivalent. The stored registry query contains 166 Knee Osteoarthritis records. Registration does not mean that a study is recruiting, that a person is eligible, or that treatment and travel are free; verify the current record and sponsor-cost terms directly.
Knee osteoarthritis is a whole-joint disorder involving cartilage, bone, synovium, muscle and mechanics. Autologous marrow or adipose preparations, culture-expanded MSCs, stromal vascular fraction and exosomes are distinct products. An anti-inflammatory signal or injection into the joint does not establish cartilage regrowth or prevention of joint replacement.
What drives the cost for Knee Osteoarthritis
Itemise assessment, exact injectate, imaging guidance, number of injections, rehabilitation, medicines, travel, follow-up and complication care. Compare with exercise, weight management where relevant, authorised symptom treatment and surgical assessment; do not treat a higher cell count or price as proof of benefit.
Studies should be assessed by exact product and processing, imaging guidance, comparator, baseline severity, pain and function outcomes, structural endpoints, rescue medication, adverse events and duration. The FDA consumer alert states that the promoted regenerative products it addresses have not been approved in the United States for orthopaedic conditions including knee pain and osteoarthritis. The NIAMS osteoarthritis guide describes established non-operative and surgical options.
Knee Osteoarthritis cost by country — comparison (2026)
| Location | Indicative treatment cost | Regulation |
|---|---|---|
| Bulgaria (EU) · e.g. Stem Plus | €3,000–€8,000 | Verify provider and laboratory certificates |
| USA | €4,600–€46,000 | Non-EU; verify provider and product status |
| UK | €4,880–€49,000 | Non-EU; verify provider and product status |
| Germany | €11,000–€36,700 | EU member state; verify provider and product status |
| Switzerland | €20,000–€40,000 | Non-EU; verify provider and product status |
| Mexico | €3,000–€12,000 | Non-EU; verify provider and product status |
| India | €3,000–€8,000 | Non-EU; verify provider and product status |
| Serbia | €7,000–€31,000 | Non-EU; verify provider and product status |
| Turkey | €6,000–€18,000 | Non-EU; verify provider and product status |
| Thailand | €8,000–€20,000 | Non-EU; verify provider and product status |
| Panama | €15,000–€27,000 | Non-EU; verify provider and product status |
Price varies with cell type, dose, number of sessions, diagnostics, supportive care and follow-up. A lower range does not establish equivalent quality or outcome. Request a fixed written quote and verify the therapy and provider with the relevant authorities. Check registered trials before paying privately.
Knee Osteoarthritis cost — common questions
Why is Knee Osteoarthritis stem-cell treatment so much cheaper in Bulgaria?
The collected commercial ranges differ, but they may describe different products, doses, visits and inclusions. A lower quote does not establish equivalent quality, evidence or regulatory status.
Is a cheaper programme riskier?
Price alone cannot establish risk. Verify the exact treatment status, provider and manufacturing authorisations, product identity, release testing, adverse-event plan and primary evidence.
Does the price include travel and hotel?
The €3,000–€8,000 range covers the medical programme. Add flights, hotel and recovery with our calculator for your true all-in cost from your city.
Will I get a fixed quote, or an open-ended bill?
Ask for a written quotation after clinical review, with the exact product, inclusions, exclusions, cancellation terms and circumstances in which charges may change. A website estimate is not a binding quote.
Sources & further reading
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
- Open clinical trials for Knee Osteoarthritis (ClinicalTrials.gov) ↗
- Peer-reviewed research on PubMed ↗
- ISSCR patient guide — what to ask ↗
- FDA consumer warning on stem-cell therapies ↗
- EMA — advanced-therapy (ATMP) framework ↗
- Clinic perspective — Stem Plus on Knee Osteoarthritis ↗
Indicative ranges for planning, compiled from public market data; confirmed pricing follows a medical review. Not medical advice.